Search

Search Results

• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7584

  PDF: 2799

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  31-38

  https://doi.org/10.4081/reumatismo.2006.31

  1936

  PDF: 2622

• CONVENTIONAL THERAPIES FOR PSORIASIS

  A. Rebora

  77-80

  https://doi.org/10.4081/reumatismo.2007.1s.77

  1028

  PDF: 985
• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1062

  6264

  PDF: 3537
• 

  Fibromyalgia and sexual problems

  L. Bazzichi, C. Giacomelli, A. Rossi, F. Sernissi, P. Scarpellini, A. Consensi, S. Bombardieri

  261-267

  28-09-2012

  https://doi.org/10.4081/reumatismo.2012.261

  3243

  PDF: 2138
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1070

  2502

  PDF: 1655
• 

  Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study

  K.T. Koh, C.L. Teh, C.K. Cheah, G.R. Ling, M.C. Yong, H.C. Hong, S.C. Gun

  90-96

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.872

  2861

  PDF: 1518

• PO:31:163 | Safety and tolerability of home-based prostacyclin analogue therapy in vascular manifestations of the scleroderma spectrum: results of a monocentric study Alice Dionisi¹, Lucrezia Verardi², Annacarla Finucci², Paola Volpe², Anna Cinzia Raspa², Paola Cipriani¹, Raffaele Zicolella² | ¹Reumatologia,Dipartimento di Sscienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila; ²UOC Reumatologia, Ospedale Civile di Pescara, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2204

  183

• The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

  I. Miniati, R. Saccardi, F. Pagliai, S. Guiducci, A. Bosi, S. Guidi, S. Urbani, A. Tyndall, M. Matucci Cerinic

  277-282

  https://doi.org/10.4081/reumatismo.2005.277

  1153

  PDF: 1592

• Sodium-gold thyosolphatum therapy: an open, viewed, multicenter trial in rheumatoid arthritis patients followed for two years

  M.L. Ciompi, C. Amoresano, P. Balzarini, L.M. Bazzichi, M. Broggini, L. Buratti, F. Calcagnile, A. Ciocci, S. Ferri, C. Fichera, M. Fumagalli, M. Muratore, F. Nitti, G. Peruz, G. Romagnoni

  251-256

  https://doi.org/10.4081/reumatismo.2002.251

  1020

  PDF: 1402

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  https://doi.org/10.4081/reumatismo.2005.4s.34

  1345

  PDF: 1449

• Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

  A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

  104-109

  https://doi.org/10.4081/reumatismo.2004.104

  1373

  PDF: 1088

• Thalidomide in treatment of connective diseases and vasculities

  N. Maruotti, F.P. Cantatore, D. Ribatti

  187-190

  https://doi.org/10.4081/reumatismo.2006.187

  1584

  PDF: 1285

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  https://doi.org/10.4081/reumatismo.2003.76

  5874

  PDF: 7773

• 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis

  Alberto Migliore, Sandro Tormenta, Umberto Massafra, Luis Severino Martin Martin, Emilia Carloni, Cristiano Padalino, Andrea Alimonti, Mauro Granata

  39-49

  https://doi.org/10.4081/reumatismo.2006.39

  1716

  PDF: 1219
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  3054

  PDF: 1328

• The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

  G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1572

  9148

  PDF: 2045

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1896

  PDF: 1089
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1489

  2109

  PDF: 1232

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1583

  PDF: 1220

• PO:02:030 | Retention Rate of Non-anti-TNF Therapies and primary failure in monocentric cohort of patients with Psoriatic Arthritis Alba Chiara Pozzi¹, Sofia Barezzani², Andrea Galli², Cesare Tomasi¹, Micol Frassi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, University of Brescia Brescia, Italy; ²Facoltà di Medicina e Chirurgia, University of Brescia Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2288

  27
• 

  Chronic pain: the burden of disease and treatment innovations

  S. Monti, R. Caporali

  35-44

  23-10-2015

  https://doi.org/10.4081/reumatismo.2015.840

  4267

  PDF: 2805

• Adherence to treatment of osteoporosis: an open question

  M. Varenna, L. Sinigaglia

  4-9

  https://doi.org/10.4081/reumatismo.2009.4

  1528

  PDF: 1035
• 

  Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis

  B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1445

  7910

  PDF: 1133
• 

  Inflammatory back pain as an unusual manifestation of Takayasu arteritis: a case report

  Faiq Gorial, Nabaa Awadh, Ali Al-Shakarchi, Ghaith Al-Gburi

  30-10-2024

  https://doi.org/10.4081/reumatismo.2024.1678

  2188

  PDF: 452

• The treatment of recurrent uveitis with TNFα inhibitors

  P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

  185-189

  https://doi.org/10.4081/reumatismo.2004.185

  1927

  PDF: 2531

• PO:02:023 | Monocentric analysis of systemic glucocorticoids in PsA: the art of balancing prescriptive appropriateness and risk factor management Chiara Crotti^{1 2}, Gilberto Cincinelli¹, Giorgia Trignani¹³, Luca Ingrao¹³, Miriam Perino¹³, Roberto Caporali¹³ | ¹Dipartimento di Reumatologia e Scienze Mediche - UOC Clinica Reumatologica, ASST Pini-CTO, Milano; ²Dipartimento di Reumatologia e Scienze Mediche - UOC Osteoporosi e Malattie Metaboliche dell Osso - ASST Pini-CTO, Milano; ³Dipartimento di Scienze Cliniche e di Comunità - Università degli Studi di Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2125

  184

• The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

  Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri

  26-30

  https://doi.org/10.4081/reumatismo.2006.26

  1100

  PDF: 1207

• Chronic osteomyelitis: a new therapeutical idea

  G. Carlino, P. Trande, M. Muratore, E. De Micheli, G. Santacesaria

  309-311

  https://doi.org/10.4081/reumatismo.2001.309

  868

  PDF: 918
• 

  Sex and gender differences in comorbidities in spondyloarthritis: a focus on psoriatic arthritis

  F. Atzeni, C. Siragusano, A. Tropea, A. Alciati

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1769

  1985

  PDF: 699

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  https://doi.org/10.4081/reumatismo.2010.248

  1396

  PDF: 756

• PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience Federica Davanzo¹, Caterina Menghi², Andrea Silvio Giordani², Anna Baritussio², Federico Scognamiglio², Cristina Vicenzetto², Luca Iorio¹, Renzo Marcolongo², Cristina Basso³, Andrea Doria¹, Roberto Padoan¹, Alida Linda Patr Caforio² | ¹Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; ²Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; ³Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2383

  35

• Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

  G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

  145-150

  https://doi.org/10.4081/reumatismo.2001.145

  1161

  PDF: 865

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  https://doi.org/10.4081/reumatismo.2007.271

  1662

  PDF: 2199

• PO:35:224 | Capturing What BVAS Misses: Patient-Reported Outcomes Reflect Disease Activity and Burden in EGPA Marta Codirenzi¹, Federica Davanzo¹, Luca Iorio¹, Eleonora Fiorin¹, Roberta Prevedello¹, Roberto Padoan¹, Andrea Doria¹ | ¹Unità di reumatologia, dipartimento di medicina DIMED,Università degli studi di Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2384

  24

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  https://doi.org/10.4081/reumatismo.2005.4s.30

  1352

  PDF: 934

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  https://doi.org/10.4081/reumatismo.2001.40

  1204

  PDF: 1106

• PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato¹, Laura Coladonato¹, Marco Fornaro¹, Marlea Lavista¹, Daniele Sabella¹, Marco Capodiferro¹, Maria Morrone¹, Crescenzio Scioscia¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area Jonica^J, University of Bari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2161

  166

• Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD

  C. Tani, M. Mosca, A. d'Ascanio, D. Versari, A. Virdis, L. Ghiadoni, S. Taddei, A. Salvetti, S. Bombardieri

  212-218

  https://doi.org/10.4081/reumatismo.2006.212

  1930

  PDF: 1438

• Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis A case report

  D. Bonanno, R. Fedele, P. Minciullo, P. Quattrocchi, B. Ferlazzo

  181-183

  https://doi.org/10.4081/reumatismo.2003.181

  2166

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  877

  PDF: 744